Financial Performance - Total revenues for the three months ended June 30, 2024, were $6,174,000, compared to $7,541,000 for the same period in 2023, representing a decrease of approximately 18.1%[7] - The net loss for the three months ended June 30, 2024, was $6,120,000, compared to a net loss of $8,663,000 for the same period in 2023, indicating an improvement of approximately 29.0%[7] - The company reported a basic and diluted net loss per share of $1.01 for the three months ended June 30, 2024, compared to $1.79 for the same period in 2023, showing an improvement of approximately 43.4%[7] - For the six months ended June 30, 2024, the net loss was $11,561,000, compared to a net loss of $12,425,000 for the same period in 2023, representing a 7% improvement[12] - The net loss for the six months ended June 30, 2024, was approximately $11.6 million, compared to a net loss of $12.8 million for the same period in 2023, showing a slight improvement[95] Assets and Liabilities - Total current assets increased to $28,765,000 as of June 30, 2024, from $28,142,000 as of December 31, 2023, reflecting a growth of about 2.2%[6] - Total liabilities rose to $6,714,000 as of June 30, 2024, compared to $4,635,000 as of December 31, 2023, marking an increase of approximately 44.8%[6] - The accumulated deficit increased to $220,324,000 as of June 30, 2024, from $208,763,000 as of December 31, 2023, representing a rise of about 5.5%[6] - Cash and cash equivalents increased to $5,802,000 as of June 30, 2024, from $2,833,000 as of December 31, 2023, indicating a significant increase of approximately 104.2%[6] - The total stockholders' equity decreased to $42,359,000 as of June 30, 2024, from $52,923,000 as of December 31, 2023, reflecting a decline of about 20.0%[6] Revenue and Operations - For the three months ended June 30, 2024, the company recognized approximately $6.2 million in revenue from operations, a significant increase from $71,000 in the same period in 2023[93] - For the six months ended June 30, 2024, the company recognized approximately $7.5 million in revenue from operations, up from $71,000 in the same period in 2023[95] - The company incurred a loss from operations of approximately $2.7 million for the three months ended June 30, 2024, compared to a loss of $9.0 million in the same period in 2023[93] Investments and Fair Value - The company reported a change in the fair value of long-term investments of $5,490,000 for the six months ended June 30, 2024, with no comparable figure for the prior year[12] - The investment in Tevva Motors was impaired by approximately $2.8 million, resulting in a valuation of $0 as of June 30, 2024[40] - The investment in Tesspay was valued at $3.4 million as of June 30, 2024, reflecting an unrealized gain of $0.7 million for the first six months of 2024[41] - The Company’s long-term equity investments totaled $24.15 million as of June 30, 2024, compared to $20.92 million as of December 31, 2023[33] Cash Flow and Financing - Cash used in operating activities for the six months ended June 30, 2024, was $7,185,000, a decrease from $13,913,000 in the prior year, indicating a 48% reduction[12] - The company reported a cash increase of $2,969,000 for the six months ended June 30, 2024, compared to a decrease of $29,576,000 in the same period of 2023[12] - Cash provided by investing activities for the six months ended June 30, 2024, was approximately $10.2 million, compared to cash used of $(14.7) million in the same period of 2023, mainly driven by sales of marketable securities totaling approximately $11.6 million[102] Corporate Strategy and Focus - Dominari Holdings Inc. has shifted its primary focus from biotechnology to fintech and financial services, establishing Dominari Financial Inc. and acquiring Dominari Securities LLC[14] - The company is winding down its historical pipeline of biotechnology assets held by Aikido Labs, LLC, focusing on its financial services strategy[90] - The company has entered into a joint venture with Heritage Strategies LLC to offer various insurance products and services, enhancing its market presence[89] Internal Controls and Legal Matters - The company experienced a material weakness in internal controls over financial reporting, affecting the accounting for certain notes receivable and long-term investments[106] - The company is facing legal proceedings related to the hiring of new registered representatives, with potential liabilities that cannot be reasonably estimated at this time[110] - The company plans to enhance controls over accounting issues by consulting with experienced third-party professionals to remediate identified weaknesses[106] Lease Agreements - The Company entered into a lease agreement with Trump Tower Commercial LLC, requiring monthly rent of $12,874, increasing to $13,502 in the sixth and seventh years[59] - Dominari Financial's lease agreement requires monthly rent of $49,368, increasing to $51,868 in the sixth and seventh years[60] - As of June 30, 2024, the company reported operating lease right-of-use assets of $3,146 million and total operating lease liabilities of $3,244 million[61]

Financial Performance - Total revenue for the three months ended March 31, 2024, was $1,367,000, compared to $0 for the same period in 2023[11] - Operating expenses increased to $4,172,000 for Q1 2024, up from $3,834,000 in Q1 2023, representing a 9% increase[11] - Net loss for the three months ended March 31, 2024, was $5,441,000, compared to a net loss of $3,762,000 in Q1 2023, indicating a 44.7% increase in losses[11] - The company recorded a net rent expense of $200,000 for the three months ended March 31, 2024, compared to $164,000 for the same period in 2023, indicating an increase of approximately 21.9%[55] - The company incurred a loss from operations of approximately $2.8 million for the three months ended March 31, 2024, compared to a loss of $3.8 million for the same period in 2023, indicating a $1.0 million decrease in net operating loss[85] - Other expenses for the three months ended March 31, 2024, were approximately $(2.6) million, primarily due to volatility in investment valuations[85] Cash and Assets - Cash and cash equivalents decreased to $1,956,000 as of March 31, 2024, down from $2,833,000 at the end of 2023, a decline of 30.8%[9] - Total assets decreased to $52,194,000 as of March 31, 2024, from $57,558,000 at the end of 2023, a reduction of 9.4%[9] - Stockholders' equity decreased to $47,669,000 as of March 31, 2024, down from $52,923,000 at the end of 2023, a decline of 10%[9] - As of March 31, 2024, the Company held approximately $14.1 million in deposits with its clearing broker[27] - As of March 31, 2024, the company's working capital amounted to approximately $23.8 million, which is expected to be sufficient to meet its working capital and capital expenditure requirements for at least the next 12 months[87] Investments - The company reported a change in fair value of long-term equity investments resulting in a loss of $2,459,000 for Q1 2024[11] - The Company’s long-term equity investments totaled $20.9 million as of March 31, 2024, down from $24.2 million as of December 31, 2023[36] - The investment in Unusual Machines, which went public on February 14, 2024, was valued based on its market price as of March 31, 2024[39] - The Company recognized revenue under ASC 606, with various revenue streams including underwriting services, commissions, and account advisory fees[29] - The unrealized gain on the Convergent Convertible Note for the three months ended March 31, 2024, was approximately $60,000[42] - The company reported a gain of approximately $0.6 million on marketable securities for the three months ended March 31, 2024, driven by market improvement and increased sale activity[86] Shareholder Information - The weighted average number of shares outstanding increased to 5,995,065 for Q1 2024, compared to 5,305,513 for Q1 2023, reflecting a 13% increase[11] - As of March 31, 2024, the company had 5,995,065 shares of common stock issued and 5,934,917 shares outstanding[57] - The company has approximately $0.2 million in unrecognized stock-based compensation expense related to restricted stock awards as of March 31, 2024[61] - The company has 444,796 warrants outstanding as of March 31, 2024, with a weighted average exercise price of $29.25 and a remaining contractual life of 1.95 years[59] Legal and Compliance - The company is currently involved in a legal proceeding related to the hiring of new registered representatives, but it cannot predict the outcome or estimate any potential loss[65] - A material weakness was identified in the accounting for certain notes receivable and long-term investments, leading to incorrect initial accounting[95] - Management plans to enhance controls by consulting experienced third-party professionals to remediate the identified material weakness[95] - The company's disclosure controls and procedures were found to be ineffective due to a material weakness in internal controls[93] - The company is involved in legal proceedings related to the hiring of new registered representatives, with potential exposure that cannot be reasonably estimated[101] Strategic Initiatives - Dominari Financial acquired Dominari Securities LLC for a total of $3.4 million, enhancing its position in the financial services sector[20] - Dominari Financial seeks partnership opportunities and acquisitions of third-party financial assets to execute its growth strategy in the financial services industry[78] - The company is winding down its historical pipeline of biotechnology assets held by Aikido Labs, LLC, which includes patented technology for various treatments[79] Cash Flow - Net cash used in operations for the three months ended March 31, 2024, was approximately $8.6 million, primarily due to a net loss of approximately $5.4 million[89] - Net cash provided by investing activities for the three months ended March 31, 2024, was approximately $7.7 million, resulting from sales of marketable securities[90] - The company had no cash flows from financing activities for the three months ended March 31, 2024, compared to approximately $0.9 million used in financing activities for the same period in 2023[91]

Financial Performance - For the fiscal year ended December 31, 2023, the company recognized approximately $2.0 million in revenue from operations, primarily driven by underwriting revenue from Dominari Securities[155]. - The company incurred a loss from operations of approximately $21.8 million in 2023, compared to a loss of $14.3 million in 2022, indicating an increase in operational losses[155]. - General and administrative expenses increased by approximately $12.2 million, largely due to professional fees and increased compensation expenses related to the establishment of Dominari Financial and Dominari Securities[157]. - Research and development expenses decreased by approximately $2.7 million, reflecting the company's strategic shift away from the biotechnology industry towards financial services[157]. - Net cash used in operations for the year ended December 31, 2023, was approximately $22.2 million, compared to $10.6 million in 2022, primarily due to a net loss of approximately $22.9 million[162]. Working Capital and Cash Flow - As of December 31, 2023, the company's working capital amounted to approximately $26.5 million, with expectations that cash and cash equivalents will meet capital requirements for at least the next 12 months[159]. - Net cash used in investing activities for 2023 was approximately $7.2 million, down from $14.6 million in 2022[163]. - Cash used in investing activities in 2023 included purchases of marketable securities of approximately $34.1 million and acquisition of FPS for approximately $1.1 million[163]. - Cash used in financing activities for 2023 was approximately $0.9 million, reflecting the cost for the purchase of treasury stock[164]. - In 2022, cash used in financing activities was approximately $7.2 million, primarily due to the redemption of Series O and Series P Redeemable Convertible Preferred Stock costing approximately $22.0 million[164]. - The company sold marketable securities worth approximately $27.6 million in 2023, partially offsetting cash used in investing activities[163]. - The company collected approximately $1.1 million on note receivable in 2023, contributing to cash flow from investing activities[163]. - In 2022, cash used in investing activities included purchases of marketable securities of approximately $26.8 million and investments of approximately $15.0 million[163]. Strategic Initiatives - The company completed the acquisition of 100% of a dually-registered broker-dealer and investment advisor, renamed Dominari Securities, on March 27, 2023, as part of its growth strategy in the financial services industry[141]. - The company is winding down its historical pipeline of biotechnology assets held by Aikido Labs, LLC, which includes prospective treatments for various diseases[142]. Accounting and Compliance - The company is evaluating the impact of new accounting standards, including ASU 2022-03, which clarifies the fair value measurement of equity securities subject to contractual sale restrictions[153]. - The company had no contractual obligations reported[165]. - As a smaller reporting company, the company is not required to provide market risk disclosures[166]. Marketable Securities - The company recognized a gain of approximately $0.6 million on marketable securities for the year ended December 31, 2023, a significant improvement from the previous year's losses[156].

Eric Newman Appointed as Executive Vice President  NEW YORK, March 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed financial industry veteran, Eric Newman, to the role of Executive Vice President of Dominari Securities enriching the firm's investment banking expertise and bolstering its brokerage operations. Mr. Newman reports directly to CEO Kyle Wool and is responsible for managing the day-to ...

Dr. Cosme Ordoñez Appointed Head of Investment Banking NEW YORK, March 12, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed Dr. Cosme Ordoñez to the role of Head of Investment Banking, Investment Banking Principal and bolstering the firm's coverage in the healthcare sector. Dr. Ordoñez has more than 20 years of investment banking and healthcare experience. Most recently, he served as Senior Managin ...

Adds High Producing Private Equity Team of Larry Cohen and John Russo and Seasoned Specialty Finance Executive Michael Siek NEW YORK, March 7, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has further expanded its practice to include the high-producing private equity investment banking team of Larry Cohen and John Russo and senior manager and director Michael Siek. The three executives join Dominari Securities ...

Adds David Reimer, Peter Sandler and team of five experienced wealth management professionals NEW YORK, March 6, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has expanded its wealth management team to include Mr. David Reimer, CEO of Gotham Equities; Wealth Advisor, Mr. Peter Sandler, and a team of five experienced wealth management professionals from Gotham Equities. Mr. Sandler will serve as a Managing Dire ...

Adds seasoned Wealth Advisors, Michael Schiavello and Billy Takos, and team of 12 experienced wealth advisors NEW YORK, March 5, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has further expanded its wealth management practice to include a team of 12 seasoned wealth advisors led by Mr. Michael Schiavello and Mr. Billy Takos.  Mr. Schiavello and Mr. Billy Takos will serve as Managing Directors and Co-Heads of P ...

Adds wealth management talent in support of 'growth and development' strategy NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, is growing its wealth management team with the addition of senior wealth management executive Mr. Raymond Guarini. Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "A principal component of our 'growth and development' strategy is hiring and retaining wealth ma ...

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, acted as lead underwriter to Unusual Machines (NYSE American: UMAC), an emerging leader in first-person view (FPV) drone technology, in an initial public offering ("Offering") of 1,250,000 shares of common stock at a public offering price of $4.00 per share for gross proceeds of $5.0 million before deducting underwriting discounts and other relat ...